Home > Offer to Sell > Intermediates > Pharmaceutical intermediates > Oxytocin Injection raw material / Oxytocin Solution / Oxytocin Acetate
Oxytocin Injection raw material / Oxytocin Solution / Oxytocin Acetate
Inquiry
| Post Date: | Mar 13,2018 |
| Expiry Date: | Mar 13,2019 |
| Detailed Description: |
Cas No. :50-56-6
Quantity: 1000Metric Tons Specs:10ampules/box Payment Method: TT/LC Specifications 0.5ml:2.5u 1ml:5u 2ml:10u [Composition] Oxytocin, made by chemical synthesis. Structural formula: H-Cys-Tyr-Ile-Glu(NH2)-Asp(NH2)-Cys-Pro-Leu-Gly-NH2 Auxiliary material: water for injection [Characteristics] This product is colorless or nearly colorless transparent liquid. [Indications] This product is for treatment of uterine hemorrhage caused by uterine atony or lack of uterine contraction during induction of labor, hastening parturition, and after childbirth or abortion. For getting known of reserve function of placenta (oxytocin challenge test). [Specifications] 0.5ml : 2.5 units (2) 1ml: 5units (3) 1ml: 10units [Usage] For induction of labor or hastening parturition: intravenous drip, 2.5-5 units at a time, diluting with sodium chloride injection to per 1ml containing 0.01unit. At the beginning of intravenous drip, it shouldn’t drip faster than 0.001-0.002units per minute, increasing 0.001-0.002units per 15-30 minutes, until uterine contraction reach similar level of normal labor term. The fastest dripping speed shouldn’t exceed 0.02units per minute, and 0.002-0.005units per minute is normal speed. For controlling postpartum hemorrhage: intravenous drip speed is 0.02-0.04units per minute, after delivery of the placenta, 5-10units could be injected intramuscularly. |
| CAS Registry Number: | 50-56-6 |
| Synonyms: | ;oxytocin lyophilized;H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 Disulfide bond;H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 (Disulfide bond);oxtocin;(2s)-1-[(4r,7s,10s,13s,16s,19r)-19-amino-13-[(2s)-butan-2-yl]-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-n-[(1s)-1-(carbamoylmethylcarbamoyl)-3-methyl-butyl]pyrrolidine-2-carboxamide;Oxytocin Solution;1-{[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-L-leucylglycinamide;1-{[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-L-leucylglycinamide acetate (1:1); |
| Molecular Formula: | C43H66N12O12S2 |
| Molecular Weight: | 1007.19 |
| Molecular Structure: | 
|
| Company: | ANHUI BBCA PHARMACEUTICAL CO., LTD [ China ] |
| Contact: | Eric |
| Tel: | +86-551-64846025 |
| Fax: | +86-551-64846082 |
| Email: | ericbiden@hotmail.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
